Home » All » Stock Forecast » BioCryst Pharmaceuticals Inc. Common Stock Forecast

BioCryst Pharmaceuticals Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -6.64%Market Cap $2.15B · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$8.75 ▲ +1.94%	Yesterday	$8.51 ▼ -0.82%	Tomorrow's BioCryst Pharmaceuticals Inc. Common Stock (BCRX) setup is anchored to $8.58 and targets $8.75 (+1.94%). The near-term read is upside; watch $8.84 / $8.32 because daily realized volatility is about 8.00%.
Tomorrow's BioCryst Pharmaceuticals Inc. Common Stock (BCRX) setup is anchored to $8.58 and targets $8.75 (+1.94%). The near-term read is upside; watch $8.84 / $8.32 because daily realized volatility is about 8.00%.
Week	$9.10 ▲ +6.05%	Last Week	$8.36 ▼ -2.54%	The 7-day BioCryst Pharmaceuticals Inc. Common Stock model moves from $8.36 to $9.10 (+6.05%). It gives upside momentum context for this stock, so breaks around $8.84 / $8.32 matter more than a single tick.
The 7-day BioCryst Pharmaceuticals Inc. Common Stock model moves from $8.36 to $9.10 (+6.05%). It gives upside momentum context for this stock, so breaks around $8.84 / $8.32 matter more than a single tick.
Month	$9.69 ▲ +12.89%	Last Month	$8.12 ▼ -5.41%	The 1-month BioCryst Pharmaceuticals Inc. Common Stock target is $9.69 (+12.89%), compared with the live reference near $8.58. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month BioCryst Pharmaceuticals Inc. Common Stock target is $9.69 (+12.89%), compared with the live reference near $8.58. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$10.56 ▲ +23.13%	Last Year	$7.75 ▼ -9.72%	The 1-year BioCryst Pharmaceuticals Inc. Common Stock scenario points to $10.56 (+23.13%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year BioCryst Pharmaceuticals Inc. Common Stock scenario points to $10.56 (+23.13%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$12.62 ▲ +47.14%	5 Years Ago	$6.88 ▼ -19.80%	The 5-year BioCryst Pharmaceuticals Inc. Common Stock view is $12.62 (+47.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year BioCryst Pharmaceuticals Inc. Common Stock view is $12.62 (+47.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$8.75▲ +1.94%

Yesterday$8.51▼ -0.82%

Tomorrow's BioCryst Pharmaceuticals Inc. Common Stock (BCRX) setup is anchored to $8.58 and targets $8.75 (+1.94%). The near-term read is upside; watch $8.84 / $8.32 because daily realized volatility is about 8.00%.

Week$9.10▲ +6.05%

Last Week$8.36▼ -2.54%

The 7-day BioCryst Pharmaceuticals Inc. Common Stock model moves from $8.36 to $9.10 (+6.05%). It gives upside momentum context for this stock, so breaks around $8.84 / $8.32 matter more than a single tick.

Month$9.69▲ +12.89%

Last Month$8.12▼ -5.41%

The 1-month BioCryst Pharmaceuticals Inc. Common Stock target is $9.69 (+12.89%), compared with the live reference near $8.58. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$10.56▲ +23.13%

Last Year$7.75▼ -9.72%

The 1-year BioCryst Pharmaceuticals Inc. Common Stock scenario points to $10.56 (+23.13%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$12.62▲ +47.14%

5 Years Ago$6.88▼ -19.80%

The 5-year BioCryst Pharmaceuticals Inc. Common Stock view is $12.62 (+47.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$8.58	Mid
Daily Change	-6.64%	Below
Volatility Cap	20.0%	Mid
Confidence	72%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$8.58

Daily Change-6.64%

Market Cap$2.15B

Sourcenasdaq-screener

Current	$8.58	Daily Change	-6.64%
Market Cap	$2.15B	Source	nasdaq-screener

Support & Resistance Levels

$8.32Support 1

$8.58Current

$8.84Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$8.58Live reference price

Used as the anchor for generated forecast calculations.

Next Month$9.69Model projection+12.89%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

72%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

72%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in BCRX today

Bullish Scenario

$9.01

+5.00% from current

Target Price$9.01

ScenarioUpside momentum

Probability62%

Base Scenario

$9.69

+12.89%

Target Price$9.69

ScenarioCapped drift

Probability70%

Bearish Scenario

$8.15

-5.00% from current

Target Price$8.15

ScenarioVolatility drawdown

Probability28%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 77/100

24H drift+1.94%

7D drift+6.05%

30D drift+12.89%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 74/100

1M outlook+12.89%

1Y outlook+23.13%

5Y outlook+47.14%

Frequently Asked Questions

Q What is the BioCryst Pharmaceuticals Inc. Common Stock (BCRX) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), BioCryst Pharmaceuticals Inc. Common Stock is projected near $8.75 versus the current reference around $8.58. That implies a modeled move of +1.94% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for BCRX?

The weekly BioCryst Pharmaceuticals Inc. Common Stock model points to $9.10, which maps to an expected drift of +6.05% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the BioCryst Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?

The BioCryst Pharmaceuticals Inc. Common Stock 1-month target is $9.69 (+12.89%), while the 1-year target is $10.56 (+23.13%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the BioCryst Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?

The BioCryst Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $12.62 with a modeled change of +47.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are BCRX support and resistance zones right now?

For BioCryst Pharmaceuticals Inc. Common Stock, nearest resistance is around $8.32, while nearest support is around $8.84. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the BioCryst Pharmaceuticals Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.